Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 8/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.38 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.38 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL2319900 | 1.00 | MAPT (0.47) | MAPTNPSR1ALDH1A1TSHRPKM | |
| Ammonia Solution, Strong SCHEMBL668709 | 1.00 | MAPT (0.47) | MAPTNPSR1ALDH1A1TSHRPKM | |
| Ammonia Solution, Strong SCHEMBL21840 | 1.00 | MAPT (0.47) | MAPTNPSR1ALDH1A1TSHRPKM | |
| Ammonia Solution, Strong SCHEMBL21839 | 1.00 | MAPT (0.47) | MAPTNPSR1ALDH1A1TSHRPKM | |
| Ammonia Solution, Strong SCHEMBL1883384 | 1.00 | MAPT (0.47) | MAPTNPSR1ALDH1A1TSHRPKM | |
| SCHEMBL432548 | 0.99 | MAPT (0.48) | MAPTNPSR1ALDH1A1TSHRPKM | |
| SCHEMBL13458992 | 0.99 | MAPT (0.48) | MAPTNPSR1ALDH1A1TSHRPKM | |
| SCHEMBL63297 | 0.99 | MAPT (0.48) | MAPTNPSR1ALDH1A1TSHRPKM | |
| SCHEMBL14599149 | 0.99 | MAPT (0.48) | MAPTNPSR1ALDH1A1TSHRPKM | |
| SCHEMBL7915441 | 0.99 | MAPT (0.48) | MAPTNPSR1ALDH1A1TSHRPKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-60126100-A | — | — | None | — | — | JP | disclosed |
| EP-2314686-B2 | Cells producing antibody compositions | KYOWA KIRIN CO LTD (JP) | 2023-06-21 | — | — | EP | disclosed |
| EP-2278003-B2 | Method for controlling the activity of immunologically functional molecule | KYOWA KIRIN CO LTD (JP) | 2020-08-05 | — | — | EP | disclosed |
| EP-2270147-B2 | METHOD FOR CONTROLLING THE ACTIVITY OF IMMUNOLOGICALLY FUNCTIONAL MOLECULE | KYOWA KIRIN CO LTD (JP) | 2020-07-22 | — | — | EP | disclosed |
| US-10590203-B2 | Human CDR-grafted antibody and antibody fragment thereof | KYOWA KIRIN CO., LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| EP-2270150-B2 | METHOD FOR CONTROLLING THE ACTIVITY OF IMMUNOLOGICALLY FUNCTIONAL MOLECULE | KYOWA HAKKO KIRIN CO LTD (JP) | 2019-08-07 | — | — | EP | disclosed |
| US-10233475-B2 | Antibody composition-producing cell | KYOWA HAKKO KIRIN CO., LTD (JP) | 2019-03-19 | — | — | US | disclosed |
| US-10233247-B2 | Method of modulating the activity of functional immune molecules | KYOWA HAKKO KIRIN CO., LTD (JP) | 2019-03-19 | — | — | US | disclosed |
| US-10131711-B2 | Human CDR-grafted antibody and antibody fragment thereof | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2018-11-20 | — | — | US | disclosed |
| US-20180030146-A1 | HUMAN CDR-GRAFTED ANTIBODY AND ANTIBODY FRAGMENT THEREOF | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2018-02-01 | — | — | US | disclosed |
| US-20040253234-A1 | Humanized antibody against fibroblast growth factor-8 and antibody fragment thereof | KYOWA HAKKO KIRIN CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| EP-1449850-A1 | HUMAN CDR-GRAFTED ANTIBODIES AND ANTIBODY FRAGMENTS THEREOF | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-08-25 | — | — | EP | disclosed |
| EP-1422243-A1 | HUMANIZED ANTIBODY AGAINST FIBROBLAST GROWTH FACTOR−8 AND FRAGMENT OF THE ANTIBODY | Kyowa Hakko Kogyo Co., Ltd (JP) | 2004-05-26 | — | — | EP | disclosed |
| US-20040091480-A1 | Anti-fibroblast growth factor-8 monoclonal antibody | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1331266-A1 | CELLS PRODUCING ANTIBODY COMPOSITIONS | Kyowa Hakko Kogyo Co., Ltd (JP) | 2003-07-30 | — | — | EP | disclosed |
| US-20030115614-A1 | Complementarity region determination antibodies; culture product; antiinflammatory agents, autoimmune diseases, viricides, bactericides | KYOWA KIRIN CO., LTD. (JP) | 2003-06-19 | — | — | US | disclosed |
| EP-1308509-A1 | NOVEL PHYSIOLOGICALLY ACTIVE PEPTIDE AND USE THEREOF | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-05-07 | — | — | EP | disclosed |
| EP-1229125-A1 | PROCESS FOR PRODUCING POLYPEPTIDE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-08-07 | — | — | EP | disclosed |
| EP-1176195-A1 | METHOD FOR CONTROLLING THE ACTIVITY OF IMMUNOLOGICALLY FUNCTIONAL MOLECULE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-01-30 | — | — | EP | disclosed |
| JP-S60126100-A | DETERMINATION OF ACTIVITY OF ANGIOTESIN I CONVERTING ENZYME | KURABO IND LTD | 1985-07-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10233247-B2 | Method of modulating the activity of functional immune molecules | FCGR3B, FCGR1A, FCGR2A | MAPT 4454/4885NPSR1 1530/4885ALDH1A1 4580/4885 |
| US-10233475-B2 | Antibody composition-producing cell | FCGR3B, FCGR2A, FCGR1A | MAPT 1617/4885NPSR1 4566/4885ALDH1A1 4618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.